Rock Springs Capital
Baltimore, Marylandrockspringscapital.com
Overview
Rock Springs Capital is a Baltimore, Maryland based hedge fund established in 2013 that specializes in the healthcare and biotechnology sector . The firm is a long/short equity fund that also provides management services to security portfolios and portfolio management for businesses or institutional clients . They emphasize companies and/or products that Rock Springs believes address critical unmet needs . The Funds primarily focus on public equities, employing a long-term, research-intensive approach to investing in healthcare and healthcare-related industries .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Hemab | Oct 2025 | Series C | Co-investor |
| Hemab Therapeutics | Oct 2025 | Series C | Co-investor |
| Treeline Biosciences | Sep 2025 | Series A Extension | Co-investor |
| Avalyn Pharma | Jul 2025 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.